T-Cure Bioscience, Inc. is an innovative immuno-oncology company committed to delivering effective and durable cell therapies for the treatment of cancer. The Company focuses on isolating high avidity T cell receptors (TCR) that can be used to engineer a
patient’s T cells to effectively target and destroy solid tumors.
patient’s T cells to effectively target and destroy solid tumors.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2017
Main Therapeutic Focus:
Gene/Cell Therapy
Lead Product in Development:
KK-LC-1 TCR and HERV-E TCR
Development Phase of Primary Product:
Phase I
Number Of Unlicensed Products (For Which You Are Seeking Partners):
2 (NY-ESO-1 TCR class I and Class II)
Speaker
